Skip to main content
. 2020 Nov 1;41(2):345–353. doi: 10.1007/s00296-020-04736-9

Table 2.

Protective measures taken for COVID-19, source of information and influence of the pandemic

During COVID-19 pandemic
parameters
RA patients (n = 1037)
n (%)
Work affected 470 (45.3)
Mild 207 (20)
Moderate 88 (8.5)
Severe 129 (12.4)
Lost 46 (4.4)
Protective measures taken
Staying at home 612 (59)
Wearing a mask 812 (79.3)
Keeping social distancing 597 (57.6)
Using disinfectants/alcohol 492 (47.4)
Source of information on COVID-19
Physicians 428 (41.3)
Friends 424 (40.9)
Media 775 (74.7)
Social media 370 (35.7)
Websites 153 (14.8)
Others (relatives/MOH/at work) 21 (2)
Consider their knowledge sufficient 408 (39.3)
Stopped or reduced taking NSAIDs 171 (16.5)
Considered complementary therapy 228 (22)
Received HCQ for prevention 127 (12.2)
Needed hospitalization 70 (6.8)
Activity 30 (42.9)
COVID-19 26 (37.1)
Others* 14 (20)
Found Difficulty in Hospitalization 48 (4.6)
History of COVID-19 Infection
Close relatives affected 320 (30.9)
Protective measures considered 310 (29.9)
Patient with suspected COVID-19 97 (9.4)
Free after treatment 38 (39.2)
Carrier 29 (29.9)
Still infected 30 (30.9)
The disease was affected (flare) 123 (11.9)
Change in the RA medications 85 (8.2)

NSAIDs: non-steroidal anti-inflammatory drugs, HCQ: hydroxychloroquine, RA: rheumatoid arthritis, and MOH: Ministry of health. *Others: include respiratory distress and exacerbated asthma in 3, diabetic coma in 2, renal colic/stone in 2, hematologic dyscrasias in 2, uncontrolled hypertension, myocardial infarction, very low potassium, meniscal tear and abortion in one patient each